Clin2
NCT05728333Possibly a fitRecruiting

Tirofiban or alteplase before clot removal in stroke

Stroke, Acute Ischemic

Treatments studied

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests whether giving either tirofiban or alteplase through a vein before a mechanical clot-removal procedure works better for an acute ischemic stroke. It may help improve how well blood flow returns and how much recovery patients can have after treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
800 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old
  • You have symptoms of an acute ischemic stroke (from a blocked blood vessel)
  • You arrive at the hospital within 24 hours of symptom start
  • A brain scan shows a clot/blocked artery in specific places (internal carotid, M1/M2 middle cerebral, or vertebrobasilar)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06373042Not yet recruiting· Phase 2/Phase 3
Tirofiban after successful stroke clot removal

This trial tests if adding a blood thinner called tirofiban after successful clot removal can improve recovery in people with severe stroke. It is for patients who had a large blockage and are treated within 24 hours of symptoms starting.

NCT06768138Recruiting· Phase 3
Giving clot-busting medicine directly into the brain after successful blood flow restoration

This trial tests whether a clot-busting drug given directly into the brain artery can improve recovery after a major stroke caused by a blockage in the front part of the brain. The study is for people whose blood flow has already been successfully restored with standard treatments.

Nancy
NCT06987305Recruiting· Phase 3
Clot-busting medication before clot removal for late-arriving stroke

This trial tests whether adding a clot-busting medication (rhTNK-tPA) before a clot-removal procedure (thrombectomy) can improve outcomes for people who have a moderate-to-severe stroke and arrive at the hospital 4.5 to 24 hours after symptoms start. It's for those with a large artery blockage but still enough brain tissue that can be saved.

Wuhan, Hubei
NCT07727395Recruiting· Phase 3
Clot-busting drug after successful clot removal for stroke

This trial tests whether giving a clot-busting drug (alteplase) directly into the brain artery after a successful clot removal improves recovery in people with severe stroke. It is for patients who have had a thrombectomy and still have a large blocked artery in the front of the brain.

An Giang
NCT07135089Recruiting· Phase 3
Tirofiban before clot removal for large artery stroke

This trial tests whether adding a clot-preventing medication called tirofiban before a mechanical clot removal procedure can improve recovery in people with a certain type of stroke. It's for those with a large artery blockage in the front part of the brain who are able to start the procedure within 12 hours.

Shenyang, Liaoning
NCT06045156Recruiting
Tirofiban after clot-busting for stroke

This trial tests whether giving tirofiban (a blood thinner) shortly after the standard clot-busting drug tenecteplase can improve recovery from a moderate stroke. It is for people who have had a stroke within the last few hours and do not have certain risk factors like irregular heart rhythm or recent bleeding.

Changchun, Jilin

Hear when a new Stroke, Acute Ischemic trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.